Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 206 entries
View as:

Absorption and Systematic Pharmacokinetics of Topically Applied IDP-120 Gel

Phase: N/A Priority: Normal
NCT ID: NCT02850003 Org: User:
Start: 06/30/16 End: 11/30/16 Due: 11/30/17

Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT04214652 Org: User:
Start: 01/27/20 End: 03/18/21 Due: 03/18/22

One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02240108 Org: User:
Start: 10/28/14 End: 10/06/17 Due: 10/06/18

A Study of a New Drug Treatment for Acne

Phase: N/A Priority: Normal
NCT ID: NCT01326780 Org: User:
Start: 03/31/11 End: 03/31/12 Due: 03/31/13

Study Evaluating Subcutaneous Methylnaltrexone For Treatment Of Opioid-Induced Constipation In Patients With Advanced Illness

Phase: N/A Priority: Normal
NCT ID: NCT00672477 Org: User:
Start: 06/30/08 End: 02/28/13 Due: 02/28/14

Safety and Efficacy of OsmoPrep® Tablets Versus HalfLytely® and Bisacodyl Tablet Bowel Prep Kit for Colon Cleansing

Phase: N/A Priority: Normal
NCT ID: NCT01427296 Org: User:
Start: 09/16/11 End: 12/09/14 Due: 12/09/15

Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02462122 Org: User:
Start: 08/19/15 End: 11/14/16 Due: 11/14/17

(CB-01-02/02) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT00679380 Org: User:
Start: 06/30/08 End: 04/30/10 Due: 04/30/11

A 6-month Efficacy, Safety, and Tolerability Study of Rifaximin In Preventing Hepatic Encephalopathy

Phase: N/A Priority: Normal
NCT ID: NCT00298038 Org: User:
Start: 12/19/05 End: 08/15/08 Due: 08/15/09

Topically Applied IDP-118 Lotion and HP Monad Lotion in Subjects With Moderate to Severe Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT03058744 Org: User:
Start: 04/30/15 End: 01/31/17 Due: 01/31/18

An Extension Study of Methylnaltrexone Bromide (MNTX) in Participants With Advanced Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04151719 Org: User:
Start: 02/03/20 End: 02/03/24 Due: 02/03/25

Randomised, Placebo-controlled Safety and Pharmacokinetics Study of Novel Rifaximin Formulations in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04529811 Org: User:
Start: 09/24/20 End: 05/09/21 Due: 05/09/22

Evaluation of Irritation by Two Facial Gels Applied to Opposite Sides of the Face

Phase: N/A Priority: Normal
NCT ID: NCT00919191 Org: User:
Start: 04/30/09 End: 05/31/09 Due: 05/31/10

Safety of Subcutaneous Methylnaltrexone for Opioid-Induced Constipation in Patients With Advanced Illness

Phase: N/A Priority: Normal
NCT ID: NCT00672139 Org: User:
Start: 07/31/08 End: 05/31/13 Due: 05/31/14

Effect of Methylnaltrexone (MNTX) on Electrocardiogram (ECG) Parameters and Cardiac Repolarization

Phase: N/A Priority: Normal
NCT ID: NCT01363323 Org: User:
Start: 11/30/04 End: 02/28/05 Due: 02/28/06

A Randomized, Blinded, Multicenter Study to Evaluate NASHA/Dx for the Treatment of Fecal Incontinence

Phase: N/A Priority: Normal
NCT ID: NCT00605826 Org: User:
Start: 09/07/06 End: 11/23/09 Due: 11/23/10

Canadian Real World Evidence Study of Brodalumab in Plaque Psoriasis to Understand the Impact on Quality of Life and Work Productivity

Phase: N/A Priority: Normal
NCT ID: NCT05132231 Org: User:
Start: 10/22/21 End: 02/28/25 Due: 02/28/26

Compassionate Use Study of Pergolide in Patients With Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00624741 Org: User:
Start: - End: - Due: -

A One-year, Open-label Study to Assess the Safety and Effectiveness of Extended Release Tramadol HCl in the Treatment of Chronic, Non-malignant Pain.

Phase: N/A Priority: Normal
NCT ID: NCT00347685 Org: User:
Start: 10/31/00 End: 02/28/03 Due: 02/28/04

Double-Blind, Double-Dummy, 2-Period Crossover of a 20-Minute Versus a 4-hour IV of MOA-728 in Stable Methadone Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00444158 Org: User:
Start: 03/31/07 End: 07/31/07 Due: 07/31/08

Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 827

Phase: N/A Priority: Normal
NCT ID: NCT00867100 Org: User:
Start: 12/31/07 End: 09/30/09 Due: 09/30/10

Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00086541 Org: User:
Start: 06/30/04 End: 01/31/07 Due: 01/31/08

Diarrhea Predominant Irritable Bowel Syndrome in Females

Phase: N/A Priority: Normal
NCT ID: NCT00461526 Org: User:
Start: 10/31/06 End: 12/31/07 Due: 12/31/08

LTS of Siliq vs. Other Therapies Treating of Adults With Moderate-to-Severe Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT03254667 Org: User:
Start: 07/25/17 End: 11/30/31 Due: 11/30/32

Viral Kinetic Study With Viramidine in Therapy-Naive Patients With Chronic Hepatitis C

Phase: N/A Priority: Normal
NCT ID: NCT00305383 Org: User:
Start: 11/30/05 End: 05/31/07 Due: 05/31/08